Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("PORTA, Massimo")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 10 of 10

  • Page / 1
Export

Selection :

  • and

Hypertensive retinopathy : there's more than meets the evePORTA, Massimo; GROSS, Andrea; VEGLIO, Franco et al.Journal of hypertension. 2005, Vol 23, Num 4, pp 683-696, issn 0263-6352, 14 p.Article

Fungal endophthalmitis in acute leukaemiaALLIONE, Attilio; MONTANARO, Marcello; MARMONT, Filippo et al.British journal of haematology. 2004, Vol 124, Num 3, issn 0007-1048, p. 257Article

Estimating the Delay Between Onset and Diagnosis of Type 2 Diabetes From the Time Course of Retinopathy PrevalencePORTA, Massimo; CURLETTO, Giulia; CAVALLO, Franco et al.Diabetes care. 2014, Vol 37, Num 6, pp 1668-1674, issn 0149-5992, 7 p.Article

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2) : a randomised placebo-controlled trial. CommentaryMITCHELL, Paul; WONG, Tien Y; SJØLIE, Anne Katrin et al.Lancet (British edition). 2008, Vol 372, Num 9647, issn 0140-6736, 1361-1363, 1385-1393 [12 p.]Article

Infant and Toddler Type 1 Diabetes: Complications after 20 years' durationSALARDI, Silvana; PORTA, Massimo; MALTONI, Giulio et al.Diabetes care. 2012, Vol 35, Num 4, pp 829-833, issn 0149-5992, 5 p.Article

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes : randomised, placebo-controlled trials. CommentaryMITCHELL, Paul; WONG, Tien Y; CHATURVEDI, Nish et al.Lancet (British edition). 2008, Vol 372, Num 9647, issn 0140-6736, 1361-1363, 1394-1402 [12 p.]Article

Markers of insulin resistance are strong risk factors for Retinopathy incidence in Type 1 diabetes: The EURODIAB Prospective Complications StudyCHATURVEDI, Nish; SJOELIE, Anne-Katrin; PORTA, Massimo et al.Diabetes care. 2001, Vol 24, Num 2, pp 284-289, issn 0149-5992Article

Human mesenchymal stem cell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetesFAVARO, Enrica; CARPANETTO, Andrea; PERIN, Paolo Cavallo et al.Diabetologia (Berlin). 2014, Vol 57, Num 8, pp 1664-1673, issn 0012-186X, 10 p.Article

Association of Autoimmunity to Autonomic Nervous Structures With Nerve Function in Patients With Type 1 Diabetes: A 16-Year Prospective StudyZANONE, Maria M; RAVIOLO, Alessandro; COPPO, Eleonora et al.Diabetes care. 2014, Vol 37, Num 4, pp 1108-1115, issn 0149-5992, 8 p.Article

Group visits improve metabolic control in Type 2 diabetes: A 2-year follow-upTRENTO, Marina; PASSERA, Pietro; TOMALINO, Marco et al.Diabetes care. 2001, Vol 24, Num 6, pp 995-1000, issn 0149-5992Article

  • Page / 1